NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders
Public ClinicalTrials.gov record NCT00053989. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Non-Myeloablative Allogeneic Hematopoietic Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies and Disorders
Study identification
- NCT ID
- NCT00053989
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Roswell Park Cancer Institute
- Other
- Enrollment
- 41 participants
Conditions and interventions
Conditions
Interventions
- allogeneic bone marrow transplantation Procedure
- anti-thymocyte globulin Biological
- cyclophosphamide Drug
- fludarabine phosphate Drug
- graft-versus-tumor induction therapy Biological
- methylprednisolone Drug
- mycophenolate mofetil Drug
- peripheral blood stem cell transplantation Procedure
- sargramostim Biological
- tacrolimus Drug
- therapeutic allogeneic lymphocytes Biological
- umbilical cord blood transplantation Procedure
Procedure · Biological · Drug
Eligibility (public fields only)
- Age range
- 4 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 28, 2002
- Primary completion
- Jul 18, 2018
- Completion
- Jul 18, 2018
- Last update posted
- Feb 9, 2020
2002 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Roswell Park Cancer Institute | Buffalo | New York | 14263-0001 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00053989, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2020 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00053989 live on ClinicalTrials.gov.